Biological Fluid-Mediated Transport Mechanisms for Targeted Drug Delivery in Next-Generation Cancer Immunotherapy

Dr. Khemraj Deshmukh is a dedicated researcher and academician in the field of Biomedical Engineering with over more than 8 years (6 years of teaching, 1.5 years of research, and 2.5 years of industry experience). He earned his Ph.D. from the National Institute of Technology, Raipur, with his doctoral research focusing on the numerical study and evaluation of poly-electrolyte complex scaffolds under cryogenic conditions. His expertise spans computational dynamics, biomaterials, cryogenic heat transfer, cell culture fluid dynamics, soft materials, 3D bioprinting, and automation and control. He has published extensively in reputed SCI and Scopus-indexed journals, contributing over 30 research papers, book chapters, and conference proceedings. Notable works include studies on scaffold degradation undercryogenic environments, flow dynamics in microchannels, and nanotechnology-based drug delivery. His interdisciplinary research also extends to artificial intelligence applications in healthcare and biomedical signal processing. In addition, he has authored several book chapters with IOP Publishing and holds both utility and design patents, including innovations such as a programmable cryogenic chamber and advanced biomedical devices. Dr. Deshmukh has successfully supervised 9 M.Tech dissertations and is currently guiding a 1 Ph.D. scholar. He has led projects funded by national agencies (40 lakh), including the fabrication of a 3D printer–based rotatory bioreactor for vascular tissue engineering. His achievements include the design and validation of a functional 3D bioprinter and development of compact cryogenic storage systems. A member of professional bodies and an active participant in international conferences, he continues to make impactful contributions to biomedical engineering research and education.Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran , India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies. Dr. Gourav Singh is an accomplished researcher in medicinal chemistry with a keen focus on neurodegenerative diseases, especially Alzheimer's disease (AD). He earned his PhD from the Indian Institute of Technology (IIT) BHU, working under the mentorship of Dr Gyan Prakash Modi. His doctoral research centered on the rational design, synthesis, and biological evaluation of small molecules aimed at therapeutic intervention. Dr. Singh has co-authored ten research articles in high-impact journals, including ACS Chemical Neuroscience, European Journal of Medicinal Chemistry, and Bioorganic & Medicinal Chemistry. With a strong interdisciplinary foundation spanning organic synthesis, computational drug design, and biological validation, Dr. Singh effectively bridges chemistry and neuropharmacology. His work significantly advances translational drug discovery efforts targeting neurodegenerative disorders. Dr. Jitendra Kumar (Ph.D., Biomedical Engineering) is currently serving as an Assistant Professor in the Department of Biomedical Engineering at B.V. Raju Institute of Technology, Narsapur (Hyderabad). He earned his doctoral degree in Biomedical Engineering from the National Institute of Technology Raipur, India, in 2024, with his thesis focused on the Design and Analysis of Bio-inspired Porous Based Hip Implant Component. He holds an M.Tech. in Instrumentation and Control Engineering from VIT Pune (2011), a B.E. in Biomedical Engineering from NIT Raipur (2007), and a PGDMM in Material Management from Annamalai University (2019). With more than eight years of academic and industry experience, including roles as Biomedical Engineer under the National Health Mission and Assistant Professor at CSVTU Bhilai and SSTC Bhilai, His research expertise in finite element analysis, orthopaedic implants, 3D printing, porous scaffold design, computational fluid dynamics, biomaterials, tissue engineering, and biomedical signal processing. His research contributions include several peer-reviewed journal publications, conference papers, and three patents filed/granted in the domain of biomedical implants and medical devices. He is proficient in advanced computational and experimental tools such as ANSYS (Structural & CFD), MATLAB, Materialise Mimics, 3D Printing, SEM, TEM, and Micro-FTIR. Dr. Kumar is a lifetime member of the Biomedical Engineering Society of India (LM-1535) and has actively participated in specialized training programs on organ printing, biomaterials, and advanced microscopy techniques. He has contributed significantly to the design and analysis of orthopedic and scaffold structures inspired by triply periodic minimal surfaces, balancing mechanical strength with additive manufacturability.

• 1. Biofluids and Cancer Immunotherapy: Fundamentals and Clinical Relevance2. Navigating the Lymphatic System: Targeting Antigen Presentation Pathways3. Bloodstream Delivery Strategies for Sustained Immunomodulation4. Mucosal Biofluid Routes: Oral, Pulmonary, and Intranasal Immunotherapy5. Exosomes and Extracellular Vesicles as Natural Delivery Vehicles6. Lipid Nanoparticles and mRNA Platforms in Cancer Vaccination7. Hydrogels and Implantable Depots for Local Immune Modulation8. Stimuli-Responsive Carriers Tuned to Biofluid Microenvironments9. Combination Immunotherapy Delivery via Biofluid-Compatible Systems10. Imaging and Pharmacokinetic Modeling in Biofluid-Mediated Delivery11. Safety, Manufacturing, and Regulatory Considerations in Clinical Translation12. Future Perspectives: Personalized and AI-Enabled Biofluid-Based Immunotherapy